Successful Treatment of Persistent Stenotrophomonas maltophilia Bacteremia With Cefiderocol in an Infant
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Successful Treatment of Persistent Stenotrophomonas maltophilia Bacteremia With Cefiderocol in an Infant
Authors
Keywords
-
Journal
Open Forum Infectious Diseases
Volume 10, Issue 4, Pages -
Publisher
Oxford University Press (OUP)
Online
2023-03-30
DOI
10.1093/ofid/ofad174
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Minocycline pharmacodynamics against Stenotrophomonas maltophilia in the neutropenic murine infection model: implications for susceptibility breakpoints
- (2022) Andrew J. Fratoni et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)
- (2022) Pranita D. Tamma et al. CLINICAL INFECTIOUS DISEASES
- Successful treatment of MDR Stenotrophomonas maltophilia-associated pneumonia with cefiderocol-based regimen in a patient with hematological malignancy
- (2022) Emanuela Zappulo et al. ANNALS OF HEMATOLOGY
- Efficacy of Cefiderocol in Experimental Stenotrophomonas maltophilia Pneumonia in Persistently Neutropenic Rabbits
- (2022) Vidmantas Petraitis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Optimised cefiderocol exposures in a successfully treated critically ill patient with polymicrobial Stenotrophomonas maltophilia bacteraemia and pneumonia receiving continuous venovenous haemodiafiltration
- (2021) Andrew J. Fratoni et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Compassionate use of cefiderocol for VIM metallo-β-lactamase-producing Pseudomonas aeruginosa infection in a toddler with Burkitt lymphoma
- (2021) Carlos D. Grasa et al. Journal of Global Antimicrobial Resistance
- Treatment refractory Stenotrophomonas maltophilia bacteraemia and pneumonia in a COVID-19-positive patient
- (2021) Zachary Pek et al. BMJ Case Reports
- Infectious Diseases Society of America Guidance on the Treatment of AmpC β-lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections
- (2021) Pranita D Tamma et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
- (2020) Matteo Bassetti et al. LANCET INFECTIOUS DISEASES
- Substantial Contribution of SmeDEF, SmeVWX, SmQnr, and Heat Shock Response to Fluoroquinolone Resistance in Clinical Isolates of Stenotrophomonas maltophilia
- (2019) Chao-Jung Wu et al. Frontiers in Microbiology
- Characterization of Phenotypic and Genotypic Diversity of Stenotrophomonas maltophilia Strains Isolated From Selected Hospitals in Iran
- (2019) Narjess Bostanghadiri et al. Frontiers in Microbiology
- Successful Treatment of Bloodstream Infection Due to Metallo-β-Lactamase-Producing Stenotrophomonas maltophilia in a Renal Transplant Patient
- (2016) Maria F. Mojica et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Efflux Pump SmeDEF Contributes to Trimethoprim-Sulfamethoxazole Resistance in Stenotrophomonas maltophilia
- (2015) María Blanca Sánchez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- 642
- (2015) Michelle Horng et al. CRITICAL CARE MEDICINE
- Cotrimoxazole - optimal dosing in the critically ill
- (2014) Glen R Brown Annals of Intensive Care
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now